Harnessing oncolytic virus-mediated immunity
Oncolytic viruses (OVs) have emerged as a promising anticancer treatment. OVs selectively infect, replicate in, and kill tumor cells. Oncolytic viral therapy occurs in two phases: an initial phase where the virus mediates direct oncolysis of tumor cells, and a second phase where an induced post-onco...
Format: | eBook |
---|---|
Language: | English |
Published: |
Frontiers Media SA
2015
|
Series: | Frontiers Research Topics
|
Subjects: | |
Online Access: | Open Access: DOAB, download the publication Open Access: DOAB: description of the publication |
Similar Items
-
Harnessing Oncolytic Virus-mediated Antitumor Immunity
by: Volker eSchirrmacher
Published: (2014-11-01) -
Exploiting tumor epigenetics to improve oncolytic virotherapy
by: Nicole E. Forbes, et al.
Published: (2013-09-01) -
Oncolytic Adenoviruses for Cancer Therapy
by: Lorella Tripodi, et al.
Published: (2021-03-01) -
Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect
by: Yokoda R, et al.
Published: (2017-11-01) -
Simultaneous Tumor and Stroma Targeting by Oncolytic Viruses
by: Anne Everts, et al.
Published: (2020-11-01)